SCHEMBL24800007

SCHEMBL24800007

CN1CCC2(CCC3C[C@@H]32)CC1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 1/20 0.32
SCN2A Q99250 1/20 0.32
SCN3A Q9NY46 1/20 0.32
SIGMAR1 Q99720 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19704094 1.00 SCN1A (0.32) SCN1ASCN2ASCN3ASIGMAR1
SCHEMBL24799370 0.92 SIGMAR1 (0.31) SIGMAR1
SCHEMBL29296034 0.81 LMNA (0.31) SCN1ASCN2ASCN3A
SCHEMBL24742875 0.71
SCHEMBL16659569 0.70 NAMPT (0.32)
SCHEMBL19122812 0.70 NAMPT (0.32)
SCHEMBL12457864 0.68 NCF1 (0.34)
SCHEMBL25621149 0.68 NCF1 (0.30)
SCHEMBL20007952 0.68 NCF1 (0.34)
SCHEMBL12457818 0.68 NCF1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4108659-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS Jacobio Pharmaceuticals Co., Ltd. (CN) 2022-12-28 EP disclosed